Literature DB >> 34480639

Inequality in place-of-death among children: a Danish nationwide study.

Sanne Lausen Wolff1, Christian Fynbo Christiansen2, Søren Paaske Johnsen2,3,4, Henrik Schroeder5, Anne-Sophie Darlington6, Bodil Abild Jespersen1, Marianne Olsen7, Mette Asbjoern Neergaard8.   

Abstract

To identify predictors for home death among children using socio-demographic factors and cause of death. It is a nationwide registry study. A cohort of children (1-17 years) who died between 1 January 2006 and 31 December 2016. It was set in Denmark, Europe. Predictors for home death were assessed: age, gender, diagnosis, region of residence, urbanicity, household income and immigrant status. Of 938 deceased children included, causes of death were solid tumours (17.3%), haematological cancers (8.5%) and non-cancerous conditions (74.2%). A total of 25% died at home. Compared to the lowest quartile, the groups with higher household income did not have a higher probability of dying at home (adjusted odds ratio (adj-OR) 0.8 (95% CI 0.5-1.2/1.3)). Dying of haematological cancers (adj-OR 0.3 (95% CI 0.2-0.7)) and non-cancerous conditions (adj-OR 0.5 (95% CI 0.3-0.7)) was associated with lower odds for home death compared to dying of solid tumours. However, being an immigrant was negatively associated with home death (adj-OR 0.6 (95% CI 0.4-0.9)). Moreover, a tendency was also found that being older, male, living outside the capital and in more urban areas were notable in relation to home death, however, not statistically significant.Conclusions: The fact that household income was not associated with dying at home may be explained by the Danish tax-financed healthcare system. However, having haematological cancers, non-cancerous conditions or being an immigrant were associated with lower odds for home death. Cultural differences along with heterogeneous trajectories may partly explain these differences, which should be considered prospectively. What is Known: • Prior studies have shown disparities in place-of-death of terminally ill children with diagnosis, ethnicity and socio-economic position as key factors. • Danish healthcare is tax-financed and in principle access to healthcare is equal; however, disparities have been found in the intensity of treatment of terminally ill children. What is New: • In a tax-financed, equal-access healthcare system, children died just as frequently at home in families with low as high household income. • Disparities in home death were related to diagnosis and immigrant status.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Child; Denmark; End-of-life; Paediatrics; Place-of-death; Youth

Mesh:

Year:  2021        PMID: 34480639     DOI: 10.1007/s00431-021-04250-5

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  4 in total

Review 1.  Predictors for place of death among children:A systematic review and meta-analyses of recent literature.

Authors:  Sanne Lausen Wolff; Christian Fynbo Christiansen; Mette Kjaergaard Nielsen; Soeren Paaske Johnsen; Henrik Schroeder; Mette Asbjoern Neergaard
Journal:  Eur J Pediatr       Date:  2020-06-30       Impact factor: 3.183

2.  Barriers to conducting advance care discussions for children with life-threatening conditions.

Authors:  Amy Durall; David Zurakowski; Joanne Wolfe
Journal:  Pediatrics       Date:  2012-03-05       Impact factor: 7.124

3.  All-cause mortality rates and home deaths decreased in children with life-limiting diagnoses in Denmark between 1994 and 2014.

Authors:  Camilla Lykke; Ola Ekholm; Kjeld Schmiegelow; Marianne Olsen; Per Sjøgren
Journal:  Acta Paediatr       Date:  2018-04-19       Impact factor: 2.299

4.  Charting the Territory: End-of-Life Trajectories for Children With Complex Neurological, Metabolic, and Chromosomal Conditions.

Authors:  Danielle Bao; Leanne Feichtinger; Gail Andrews; Colleen Pawliuk; Rose Steele; Harold Hal Siden
Journal:  J Pain Symptom Manage       Date:  2020-09-08       Impact factor: 3.612

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.